437 related articles for article (PubMed ID: 8083709)
1. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery.
Heiss MM; Mempel W; Delanoff C; Jauch KW; Gabka C; Mempel M; Dieterich HJ; Eissner HJ; Schildberg FW
J Clin Oncol; 1994 Sep; 12(9):1859-67. PubMed ID: 8083709
[TBL] [Abstract][Full Text] [Related]
2. Blood transfusions and prognosis in colorectal cancer: long-term results of a randomized controlled trial.
Harlaar JJ; Gosselink MP; Hop WC; Lange JF; Busch OR; Jeekel H
Ann Surg; 2012 Nov; 256(5):681-6; discussion 686-7. PubMed ID: 23095610
[TBL] [Abstract][Full Text] [Related]
3. Effect of perioperative blood transfusion on prostate cancer recurrence.
Ford BS; Sharma S; Rezaishiraz H; Huben RS; Mohler JL
Urol Oncol; 2008; 26(4):364-7. PubMed ID: 18367097
[TBL] [Abstract][Full Text] [Related]
4. Blood transfusions and prognosis in colorectal cancer.
Busch OR; Hop WC; Hoynck van Papendrecht MA; Marquet RL; Jeekel J
N Engl J Med; 1993 May; 328(19):1372-6. PubMed ID: 8292113
[TBL] [Abstract][Full Text] [Related]
5. Survival advantage of using autologous blood transfusion during surgery for esophageal cancer.
Motoyama S; Saito R; Kamata S; Kitamura M; Okuyama M; Imano H; Nakamura M; Suzuki H; Omokawa S; Motohashi Y; Ogawa J
Surg Today; 2002; 32(11):951-8. PubMed ID: 12444430
[TBL] [Abstract][Full Text] [Related]
6. Perioperative blood transfusions do not affect disease recurrence of patients undergoing curative resection of colorectal carcinoma: a Mayo/North Central Cancer Treatment Group study.
Donohue JH; Williams S; Cha S; Windschitl HE; Witzig TE; Nelson H; Fitzgibbons RJ; Wieand HS; Moertel CG
J Clin Oncol; 1995 Jul; 13(7):1671-8. PubMed ID: 7602357
[TBL] [Abstract][Full Text] [Related]
7. The effect of blood transfusions on survival after surgery for colorectal cancer.
Busch OR; Hop WC; Marquet RL; Jeekel J
Eur J Cancer; 1995; 31A(7-8):1226-8. PubMed ID: 7577027
[TBL] [Abstract][Full Text] [Related]
8. [Clinical effects of blood transfusion-associated immune modulation on outcome of tumor surgery].
Heiss MM; Mempel W; Delanoff C; Mempel M; Jauch KW; Schildberg FW
Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():25-9. PubMed ID: 8374284
[TBL] [Abstract][Full Text] [Related]
9. Transfusion practices among patients who did and did not predonate autologous blood before elective cardiac surgery.
Dupuis JY; Bart B; Bryson G; Robblee J
CMAJ; 1999 Apr; 160(7):997-1002. PubMed ID: 10207338
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of blood transfusions on disease-free survival in colorectal carcinoma.
Busch OR; Hop WC; Marquet RL; Jeekel J
Scand J Gastroenterol Suppl; 1993; 200():21-3. PubMed ID: 8016565
[TBL] [Abstract][Full Text] [Related]
11. Blood transfusions and local tumor recurrence in colorectal cancer. Evidence of a noncausal relationship.
Busch OR; Hop WC; Marquet RL; Jeekel J
Ann Surg; 1994 Dec; 220(6):791-7. PubMed ID: 7986147
[TBL] [Abstract][Full Text] [Related]
12. A model for predicting transfusion requirements in head and neck surgery.
Weber RS
Laryngoscope; 1995 Aug; 105(8 Pt 2 Suppl 73):1-17. PubMed ID: 7630307
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic blood transfusion in patients in Dukes B stage of colorectal cancer.
Zdravkovic D; Bilanovic D; Randjelovic T; Granic M; Djukanovic B; Ivanovic N; Dikic S; Nikolic D; Zdravkovic M; Soldatovic I
Med Oncol; 2011 Mar; 28(1):170-4. PubMed ID: 20151229
[TBL] [Abstract][Full Text] [Related]
14. Impact of perioperative allogeneic red blood cell transfusion on recurrence and overall survival after resection of colorectal liver metastases.
Schiergens TS; Rentsch M; Kasparek MS; Frenes K; Jauch KW; Thasler WE
Dis Colon Rectum; 2015 Jan; 58(1):74-82. PubMed ID: 25489697
[TBL] [Abstract][Full Text] [Related]
15. Modulation of immune response by blood transfusion: evidence for a differential effect of allogeneic and autologous blood in colorectal cancer surgery.
Heiss MM; Fraunberger P; Delanoff C; Stets R; Allgayer H; Ströhlein MA; Tarabichi A; Faist E; Jauch KW; Schildberg FW
Shock; 1997 Dec; 8(6):402-8. PubMed ID: 9421852
[TBL] [Abstract][Full Text] [Related]
16. Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group.
Mynster T; Christensen IJ; Moesgaard F; Nielsen HJ
Br J Surg; 2000 Nov; 87(11):1553-62. PubMed ID: 11091245
[TBL] [Abstract][Full Text] [Related]
17. Autologous blood donation and epoetin alfa in cancer surgery.
Jeekel J
Semin Hematol; 1996 Apr; 33(2 Suppl 2):43-6; discussion 47. PubMed ID: 8723582
[TBL] [Abstract][Full Text] [Related]
18. Effects of allogeneic blood transfusion in patients with stage II colon cancer.
Meng J; Lu XB; Tang YX; Sun GP; Li X; Yan YF; Liang GF; Ma SP; Li XX
Asian Pac J Cancer Prev; 2013; 14(1):347-50. PubMed ID: 23534751
[TBL] [Abstract][Full Text] [Related]
19. Perioperative allogeneic blood transfusion, the related cytokine response and long-term survival after potentially curative resection of colorectal cancer.
Miki C; Hiro J; Ojima E; Inoue Y; Mohri Y; Kusunoki M
Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):60-6. PubMed ID: 16477921
[TBL] [Abstract][Full Text] [Related]
20. Impact of perioperative blood transfusion on immune function and prognosis in colorectal cancer patients.
Qiu L; Wang DR; Zhang XY; Gao S; Li XX; Sun GP; Lu XB
Transfus Apher Sci; 2016 Apr; 54(2):235-41. PubMed ID: 26780991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
